Cargando…
Untargeted Lipidomic Profiling Reveals Lysophosphatidylcholine and Ceramide as Atherosclerotic Risk Factors in apolipoprotein E Knockout Mice
Despite the availability and use of numerous cholesterol-lowering drugs, atherosclerotic cardiovascular disease (ASCVD) remains the leading cause of mortality globally. Many researchers have focused their effort on identifying modified lipoproteins. However, lipid moieties such as lysophosphatidylch...
Autores principales: | Law, Shi-Hui, Chan, Hua-Chen, Ke, Guan-Ming, Kamatam, Swetha, Marathe, Gopal Kedihithlu, Ponnusamy, Vinoth Kumar, Ke, Liang-Yin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10138920/ https://www.ncbi.nlm.nih.gov/pubmed/37108120 http://dx.doi.org/10.3390/ijms24086956 |
Ejemplares similares
-
An Updated Review of Lysophosphatidylcholine Metabolism in Human Diseases
por: Law, Shi-Hui, et al.
Publicado: (2019) -
Apolipoprotein E knockout rabbit model of intracranial atherosclerotic disease
por: Zabriskie, Matthew S., et al.
Publicado: (2020) -
Lipidomic Profile Revealed the Association of Plasma Lysophosphatidylcholines with Adolescent Obesity
por: Wang, Yang, et al.
Publicado: (2019) -
Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice
por: Nagashima, M., et al.
Publicado: (2011) -
Natural Killer T Cells Are Involved in Atherosclerotic Plaque Instability in Apolipoprotein-E Knockout Mice
por: Ohmura, Yoshinori, et al.
Publicado: (2021)